Dr. Khaled Khalaf Salman Radad
My Social Links

Dr. Khaled Khalaf Salman Radad

Professor
Assiut University, Egypt

Highest Degree
DVM in Veterinary Medicine from Veterinary Medical University, Austria

Share this Profile

Biography

Dr. Khaled Radad is currently working as Assistant Professor in Department of Pathology, College of Medicine, King Khaled University, Abha, Saudi Arabia, and Lecturer of Veterinary Pathology, Department of Pathology and Clinical Pathology, Faculty of Veterinary Medicine, Assiut University, Assiut, Egypt. He obtained his DVM in Veterinary Medicine from Veterinary Medical University, Austria in 2002. He also worked as Demonstrator, Assistant Lecturer and Lecturer at Assiut University. He supervised 1 M.V.Sc student. He is also author of 1 book chapter. He also received Silver Medal from College of Medicine, King Khalid University, Abha, Saudi Arabia for the active participation on quality committee. He has published 15 research articles in journals as author/coauthor.

Area of Interest:

Animal and Veterinary Sciences
100%
Clinical Pathology
62%
Veterinary Medicine
90%
Cell Culture
75%
Toxicity
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
52
Abstracts
0

Selected Publications

  1. Radad, K., M. Al-Shraim, A. Al-Emam, R. Moldzio and W.D. Rausch, 2018. Neurotoxic effects of domoic acid on dopaminergic neurons in primary mesencephalic cell culture. Folia Neuropathol., 56: 39-48.
    CrossRef  |  Direct Link  |  
  2. Al-Emam, A., M. Al-Shraim, R. Eid, M. Alfaifi, M. Al-Shehri, M.F. Moustafa and K. Radad, 2018. Ultrastructural changes induced by Solanum incanum aqueous extract on HCT 116 colon cancer cells. Ultrastruct. Pathol., (In Press). 10.1080/01913123.2018.1447623.
    CrossRef  |  Direct Link  |  
  3. Radad, K., R. Moldzio, M. Al-Shraim, B. Kranner, C. Krewenka and W.D. Rausch, 2017. Recent advances on the role of neurogenesis in the adult brain: Therapeutic potential in Parkinson's and Alzheimer's diseases. CNS Neurol. Disord.-Drug Targets, 16: 740-748.
    CrossRef  |  Direct Link  |  
  4. Eid, R.A., M. Al-Shraim, F. El-Sayed and K. Radad, 2017. Ultrastructural changes of kidney in Schistosoma mansoni-infected mice. Ultrastruct. Pathol., 41: 320-326.
    CrossRef  |  Direct Link  |  
  5. Reichelt, D., K. Radad, R. Moldzio, W.D. Rausch, H. Reichmann and G. Gille, 2016. Comparable neuroprotective effects of pergolide and pramipexole on ferrous sulfate-induced dopaminergic cell death in cell culture. CNS Neurol. Disord.-Drug Targets, 15: 1325-1332.
    CrossRef  |  Direct Link  |  
  6. Radad, K., R. Moldzio, M. Al-Shraim, A. Al-Emam and W.D. Rausch, 2016. Comparable neuroprotective effect of rapamycin against low and high rotenone concentrations in primary dopaminergic cell culture. J. Applied Pharmaceut. Sci., 6: 142-146.
    CrossRef  |  Direct Link  |  
  7. Nguyen, C.H., C. Krewenka, K. Radad, B. Kranner and A. Huber et al., 2016. THC (Δ9-tetrahydrocannabinol) exerts neuroprotective effect in glutamate-affected murine primary mesencephalic cultures through restoring mitochondrial membrane potential and anti-apoptosis involving CB1 receptor-dependent mechanism. Phytother. Res., 30: 2044-2052.
    CrossRef  |  Direct Link  |  
  8. Hassanein, K.M.A., A. Al-Emam and K. Radad, 2016. Prophylactic effects of thymoquinone against carbon tetrachloride-induced hepatic damage in Sprague-Dawley rats. J. Applied Pharmaceut. Sci., 6: 167-171.
    CrossRef  |  Direct Link  |  
  9. Al Shraim, M., R. Eid, K. Radad and N. Saeed, 2016. Ultrastructural pathology of human liver in Rift Valley fever. BMJ Case Rep. 10.1136/bcr-2016-216054.
    CrossRef  |  Direct Link  |  
  10. Radad, K.S., M.M. Al-Shraim, M.F. Moustafa and W.D. Rausch, 2015. Neuroprotective role of thymoquinone against 1-methyl-4-phenylpyridinium-induced dopaminergic cell death in primary mesencephalic cell culture. Neurosciences, 20: 10-16.
    Direct Link  |  
  11. Meinel, J., K. Radad, W.D. Rausch, H. Reichmann and G. Gille, 2015. Cabergoline protects dopaminergic neurons against Rotenone-induced cell death in primary mesencephalic cell culture. Folia Neuropathol., 53: 29-40.
    Direct Link  |  
  12. Al-Shraim, M.M., R.A. Eid, A.O. Musalam, K. Radad, A.H. Ibrahim and T.A. Malki, 2015. Ultrastructural changes of the smooth muscle in esophageal atresia. Ultrastruct. Pathol., 39: 413-418.
    CrossRef  |  Direct Link  |  
  13. Al-Shraim, M., K. Radad, R.A. Eid and F. El-Sayed, 2015. Helicobacter pylori-induced chronic active gastritis in Saudi patients with special reference to the ultrastructural pathology. Compar. Clin. Pathol., 24: 93-99.
    CrossRef  |  Direct Link  |  
  14. Radad, K., R. Moldzio, M. Al-Shraim, B. Kranner, C. Krewenka and W.D. Rausch, 2014. Recent advances in Autophagy-based neuroprotection. Exp. Rev. Neurother., 15: 195-205.
    CrossRef  |  Direct Link  |  
  15. Radad, K., K. Hassanein, M. Al-Shraim, R. Moldzio and W.D. Rausch, 2014. Thymoquinone ameliorates Lead-induced brain damage in Sprague Dawley rats. Exp. Toxicol. Pathol., 66: 13-17.
    CrossRef  |  Direct Link  |  
  16. Radad, K., D. Scheller, W.D. Rausch, H. Reichmann and G. Gille, 2014. Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture. Folia Neuropathol., 52: 179-186.
    CrossRef  |  Direct Link  |  
  17. Radad, K. and S. Khalil, 2014. Natural ovine pulmonary adenocarcinoma in an Egyptian sheep farm. Eur. J. Vet. Sci., 30: 39-43.
    Direct Link  |  
  18. Oster, S., K. Radad, D. Scheller, M. Hesse, W. Balanzew, H. Reichmann and G. Gille, 2014. Rotigotine protects against glutamate toxicity in primary dopaminergic cell culture. Eur. J. Pharmacol., 724: 31-42.
    CrossRef  |  Direct Link  |  
  19. Radad, K., K. Hassanein, R. Moldzio and W.D. Rausch, 2013. Vascular damage mediates neuronal and non-neuronal pathology following short and long-term rotenone administration in Sprague-Dawley rats. Exp. Toxicol. Pathol., 65: 41-47.
    CrossRef  |  Direct Link  |  
  20. Moldzio, R., K. Radad, C. Krewenka, B. Kranner, J.C. Duvigneau and W.D. Rausch, 2013. Protective effects of resveratrol on glutamate-induced damages in murine brain cultures. J. Neural Trans., 120: 1271-1280.
    CrossRef  |  Direct Link  |  
  21. Radad, K., M. Al-Shraim, R. Moldzio and W.D. Rausch, 2012. Recent advances in benefits and hazards of engineered nanoparticles. Environ. Toxicol. Pharmacol., 34: 661-672.
    CrossRef  |  Direct Link  |  
  22. Eid, R.A., K. Radad and M. Al-Shraim, 2012. Ultrastructural changes of smooth muscles in varicocele veins. Ultrastruct. Pathol., 36: 201-206.
    CrossRef  |  Direct Link  |  
  23. Radad, K. and S. Khalil, 2011. Coccidiosis, paratuberculosis and enterotoxaemia in Saudi goats. Braz. J. Vet. Pathol., 4: 219-224.
  24. Eid, R., K. Radad and M. Al-Shraim, 2011. Iridoviral infection consistent with lizard erythrocytic virus in Chamaelo calyptratus. Vet. Med. Austria, 98: 82-86.
  25. Ali, M. and K. Radad, 2011. Cod liver oil/honey mixture: An effective treatment of equine complicated lower leg wounds. Vet. World, 4: 304-310.
    Direct Link  |  
  26. Al Shraim, M., M. Hasan, A. Hawan, K. Radad and R. Eid, 2011. Plantar angiomyxolipoma in a child. BMJ Case Rep., 10.1136/bcr.09.2011.4752.
    CrossRef  |  
  27. Radad, K., R. Moldzio and W.D. Rausch, 2010. Ginsenosides and Their CNS targets CNS Neurosci, 8 (In press) .
    PubMed  |  
  28. Radad, K., M. Rudolf and W.D. Rausch, 2010. Minocycline protects dopaminergic neurons against long-term rotenone toxicity. Can. J. Neurol. Sci., 37: 81-85.
    PubMed  |  
  29. Radad, K., A. Hashim and M.S. Youssef, 2010. Neuropathologic effects of methomyl on Sprage-Dawely rats. Assiut Vet. Med. J., 56: 336-353.
  30. Radad, K., 2010. How do people and researchers look to Chinese herbal medicine. Asia Pacific. Bio. News, 14: 13-15.
  31. Moldzio, R., K. Radad, C. Krewenka, B. Kranner, J.C. Duvigneau, Y. Wang and W.D. Rausch, 2010. Effects of epigallocatechin gallate on Rotenone-injured murine brain cultures. J. Neural Trans., 117: 5-12.
    CrossRef  |  Direct Link  |  
  32. Sayed, S.M., A. El-Ella, N.M. Wahba, N.A.E. Nisr and K. Raddad et al., 2009. Immune defense of rats immunized with fennel honey, propolis and bee venom against induced staphylococcal infection. J. Med. Food, 12: 569-575.
  33. Rausch, W.D., W. Lin, O. Entkhtavian, M. Rudolf and Li Qinfan et al., 2009. Neuronal changes in aging, oxidative stress and neuroprotective mechanisms. Wiener Klinische Wochen schrift, 121: 50-51.
  34. Radad, K., A. Hashim, E.E.G..El-Sharqawy and M.S. Youssef, 2009. Histopathological effects of methomyl on Sprage-Dawley rats after repeated application. Bulg. J. Vet. Med., 12: 149-157.
  35. Radad, K., R. Moldzio, M. Taha, W.D. Rausch, 2008. Thymoquinone protects dopaminergic neurons against MPP+ and rotenone. Phytother. Res., 23: 696-700.
    PubMed  |  
  36. Moldzio, R., C. Piskernik, K. Radad, W.D. Rausch, 2008. Rotenone damages striatal organotypic slice culture. Ann. N. Y. Acad. Sci., 1148: 530-535.
    PubMed  |  
  37. Radad, K., G. Gille, X. Jia, D. Nuria and W.D. Rausch, 2007. CDP-choline reduces dopaminergic cell loss induced by MPP + and glutamate in primary mesencephalic cell culture. Inter. J. Neurosci., 117: 985-998.
    PubMed  |  
  38. Radad, K., G. Gille and W.D. Rausch, 2007. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture. Toxicol. in vitro, 22: 68-74.
    PubMed  |  
  39. Radad, K., A. Marwah, K.A. Sary and M.S. Youssef, 2007. Pathology in goats associated with super-phosphate emissions. J. Vet. Res., 11: 10-19.
    Direct Link  |  
  40. Radad, K. and M. El-Shazly, 2007. Clinical and pathological assessment of different suture techniques for microvascular anastomosis in rat femoral artery. J. Vet. Sci., 8: 269-273.
    CrossRef  |  
  41. Moldzio, R., K. Radad, C. Piskernik, C. Duvigneau, C. Krewenka and W.D. Rausch, 2007. Influence of gabapentin on morphological changes induced by epileptiform activity in hippocampus in vitro. Wien. Tierarztl. Mschr., 94: 3-9.
    Direct Link  |  
  42. Radad, K., G. Gille, L. Liu and W.D. Rausch, 2006. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J. Pharmacol. Sci., 100: 175-186.
    Direct Link  |  
  43. Radad, K., G. Gille and W.D. Rausch, 2006. Rotenone induces cell death in primary dopaminergic culture by increasing ROS production and inhibiting mitochondrial respiration. Neurochem. Int., 49: 379-386.
    PubMed  |  
  44. Radad, K. and F.A. Moustafa, 2006. Studies on Pasteurella multocida and other bacterial pathogens associated with some problems in duck farms in assiut governorate. Assiut. Vet. J., 52: 336-353.
  45. Moldzio, R., K. Radad, J.C. Duvigneau, B. Kranner, C. Krewenka, C. Piskernik and W.D. Rausch, 2006. Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture. J. Neural Transm., 113: 1095-1105.
    PubMed  |  
  46. Fathy, A. and K. Radad, 2006. Surgical treatment and histopathology of different forms of olecranon and presternal bursitis in cattle and buffalo. J. Vet. Sci., 7: 287-291.
    PubMed  |  Direct Link  |  
  47. Radad, K., G. Gille and W.D. Rausch, 2005. Short review on dopamine agonists: Insight into clinic and research studies relevant to Parkinson's disease. Pharmacol. Rep., 57: 701-712.
    PubMed  |  
  48. Gille, G., K. Radad, H. Reichmann and W.D. Rausch, 2005. Synergistic effect of a-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture. J. Neural Transm., 113: 1107-1118.
    PubMed  |  
  49. Radad, K., G. Gille, R. Moldzio, H. Saito, K. Ishige and W.D. Rausch, 2004. Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP +-affected mesencephalic dopaminergic cells. J. Neural Transm., 111: 37-45.
    CrossRef  |  
  50. Radad, K, G. Gille, R. Moldzio, H. Saito and W.D. Rausch, 2004. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res., 1021: 41-53.
    PubMed  |  
  51. Radad, K., G. Gille and W.D. Rausch, 2003. Neuroprotective effects of ginsenosides: mechanisms in primary dopaminergic cell culture. Med. Rep., 4: 27-27.